Silicon balance in human volunteers; a pilot study to establish the variance in silicon excretion versus intake. by Pruksa, Supannee et al.
Pruksa et al. Nutrition & Metabolism 2014, 11:4
http://www.nutritionandmetabolism.com/content/11/1/4RESEARCH Open AccessSilicon balance in human volunteers; a pilot study
to establish the variance in silicon excretion
versus intake
Supannee Pruksa1, Atitaya Siripinyanond2, Jonathan J Powell3 and Ravin Jugdaohsingh3*Abstract
Background: Accumulating evidence suggests a role for silicon in optimal connective tissue health. Further proof
of its importance/essentiality may be provided by studies involving imposed depletion followed by 29Si challenge
to estimate metabolic balance. Prior to conducting these expensive studies, we first established the variance of
estimating normal Si excretion versus intake using a single oral dose of typical dietary Si, orthosilicic acid.
Methods: Healthy volunteers were recruited from Loei Rajabhat University, separated into two matched groups
(three males and three females/group) and maintained on a standardized diet for the three study days. One group
ingested 500 ml water containing orthosilicic acid (28.9 mg Si) and the other group received 500 ml water alone, all
on a fasted stomach. Blood samples and total urine and faeces were collected over the 48 h post-dose period and
24 h before-hand (baseline) and analysed for silicon by inductively coupled plasma optical emission spectrometry.
Results: Serum Si analysis confirmed the ready absorption of silicon from the orthosilicic acid solution. Mean total
urinary and faecal Si excretions over the 24 h post-dose period accounted for 57 ± 9.5% and 39 ± 9.4% of the
ingested dose, respectively. Thus in total 96.3 ± 5.8% of the ingested dose was recovered in faecal plus urinary
excretions over the 24 h post-dose period.
Conclusions: We report that in healthy subjects (presumably in Si balance), the ingestion of a soluble dose of
dietary Si results in the same quantity (within analytical error) being excreted within 24 h. It is currently not known
if this all originated from the dose solution or if there was some exchange with the body Si pool but, given the low
variance in these silicon balance data, isotopic studies are now merited.
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Silicon is a critical element in the biology and/or survival
of a number of lower life forms, including diatoms, certain
sponges and many plants [1-4]. In humans and other
mammals its role (if any) is less well defined despite
being a common dietary trace element (20–50 mg/day is
ingested by adults in western populations [5-8]). Indeed,
the environmental ubiquity and limited (bio) chemistry of
silicon have led to claims that its ingestion, ready absorp-
tion and excretion by mammals are all simply inevitable
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stated.(orthosilicic acid, Si(OH)4) that ‘washes through’ the system
and has no biological function [9,10]. Against this, evidence
is accumulating to suggest that, in mammals, silicon plays
an important role in optimal connective tissue health
[11-14]. Its exact role/function remains unestablished, but
there is evidence to suggest it’s involved in the synthesis
and/or stabilisation of extracellular matrix components,
namely collagen, and in the proliferation of connective
tissue cells [9,14]. There is also evidence to suggest that
silicon is carefully conserved when dietary deficiency is
imposed [15,16]. To translate these findings to humans,
and provide more evidence for its essentiality, balance
studies using Si isotope(s) following a low silicon diet may
demonstrate (i) retention of silicon following ingestionLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Table 1 Characteristics of the study volunteers
Characteristics Control group
(3 M & 3 F)
Si-supplemented
group (3 M & 3 F)
Mean ± SD Range Mean ± SD Range
Age (y) 21.2 ± 1.9 (18.1–23.1) 21.0 ± 1.3 (19.0–22.0)
Weight (kg) 55.1 ± 7.3 (45.2–65.4) 56.4 ± 6.6 (50.0–66.8)
Height (cm) 163 ± 10 (155–176) 165 ± 8 (157–176)
BMI (kg/m2) 20.6 ± 1.7 (18.1–22.7) 20.8 ± 2.5 (18.2–25.0)
Serum creatinine1
(mg/dL)
0.92 ± 0.15 (0.80–1.10) 0.88 ± 0.15 (0.80–1.10)
Baseline 24 h
Si excretion:
Urine
(mg/24 h)
12.48 ± 2.26 (9.72–15.31) 12.93 ± 2.85 (9.11–16.34)
Faeces
(mg/24 h)
9.50 ± 1.41 (7.99–11.48) 9.35 ± 2.01 (6.68–11.47)
1Normal creatinine levels: male 0.9-1.3, female 0.6-1.1 mg/dL.
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some endogenous silicon or is simply washed through.
Despite the simple form of balance studies, where quan-
titative faecal and urinary excretion of a substance (and/or
metabolites) are compared to the amount of substance
ingested, they are fraught with difficulties [17]. Faecal
collection and analysis is especially demanding: gastrointes-
tinal transit times vary between individuals and temporary
mucosal retention of a substance may also occur, adding
further variability. Volunteers must provide complete
collections and analysis of different fractions and sample
types causes inevitable compound error.
For silicon, a basic human balance study, no matter
how precise or accurate, would tell us little about the
homeostasis of the element. If silicic acid is not utilised/
metabolised, but is washed through the system, then a
perfect study would recover 100% of the ingested dose.
On the other hand, if it were utilised and/or metabolised,
a 100% recovery would still be expected assuming that
volunteers are themselves in balance (i.e. not deficient).
Nonetheless, the value of such a study would be to deter-
mine what sort of variance one might expect in balance if
this were to be attempted in subsequent isotope and/or
depletion studies (i.e. are these expensive and time consum-
ing studies worth doing?). It would also have the added
value of confirming whether urinary silicon, which is
typically used to estimate silicon absorption in humans, is
a valid measure for this purpose.
Here we sought to determine the balance in excretion
of silicon (faecal and urinary) versus intake, using a single
oral dose of silicic acid (28.9 mg Si) in human volunteers
on a standardized diet.
Subjects and methods
Subjects
Fourteen healthy volunteers (seven males and seven
females, aged 18–23 years old) were recruited by adver-
tisement on notice boards at Loei Rajabhat University,
Thailand. Two subjects (one male and one female) were
excluded due to fainting during blood collection at
the screening stage. The remaining 12 subjects were
self-reportedly healthy with normal renal function, as
assessed by serum creatinine, and were not taking Si
supplements and/or medicines containing Si and were
not pregnant or lactating. The 12 subjects were divided
into two groups of six, matched for age, body mass index
(BMI) and male to female ratio. One group ingested
500 mL UHP water (Control group) and the other
group 500 ml of the Si supplement solution (28.9 mg
Si; Si-supplemented group). Anthropogenic data (age,
height, weight, BMI and serum creatinine) were collected
for each participant and there was no significant difference
in subject characteristics between the two groups (Table 1).
The study was conducted according to the guidelines laiddown in the Declaration of Helsinki and was approved
by the Loei Rajabhat University Local Research Ethics
Committee. All participants gave signed written consent
following oral and written explanation of the study details.Materials
Glassware was avoided throughout the study to pre-
vent Si contamination. Ultra high purity (UHP) water
was from a water purifier (Labscan Asia Co Limited,
Bangkok, Thailand). The stock basic sodium silicate so-
lution was from Lakehead University, Canada (Professor
Stephen Kinrade). The stock silicon ICP standard solution
(1,000 mg/L Si) was from Merck Ltd (Poole, UK). Nitric
acid (65% (w/v) HNO3) and hydrochloric acid (37%) were
high purity from RCI Labscan Limited (Bangkok, Thailand).
Polypropylene tubes (15 and 50 mL) were from Elkay
Laboratory Products UK Ltd (Basingstoke, UK). Poly-
propylene bottles (30 and 2,000 mL) were from VWR
International (Poole, UK). All intravenous catheters
(1.2 × 45 mm) and plastic syringes were from Nipro Ltd
(Pranakhonsriayuthaya, Thailand). Pasteur pipettes (3.5 mL),
used for sample transfer, were from Greiner Bio-One
Limited (Stonehouse, UK). Pipette tips (100–1,000 μL)
were from Hycon (Biomed C. Ltd., Bangkok, Thailand).Preparation of Si supplement
The Si supplement (orthosilicic acid solution, OSA) was
prepared fresh, just prior to ingestion, by dilution of the
stock basic sodium silicate solution (1.58 mol Si/L or
45.72 g Si/L) into UHP water and pH neutralization to
7.2 with HCl. The Si concentration in the test solution
(2.06 mmol/L or 57.78 mg/L) was confirmed by inductively
coupled plasma – optical emission spectrometry (ICP-OES;
Perkin Optima, model 2100 DV).
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Twenty four hours prior to ingestion of the test solu-
tions (study day 0), all subjects collected 24 h urines (as
two 12 h collections) and faeces (one 24 h collection) for
baseline Si measurements. All subjects fasted overnight
from 22.00 h and reported, still fasted, to Loei Rajabhat
University the following morning (study day 1) at 08.00 h
where they emptied their bladder and bowel into containers
(part of 24 h baseline collections) and had an intravenous
catheter inserted into a forearm vein. Two 10 mL blood
samples were collected into polypropylene tubes for
baseline Si measurements. Subjects were given 500 mL
of the test solution (Si supplement or water) and asked
to consume it as quickly as possible, i.e. within 10–15 min.
Thereafter, further blood samples (10 mL) were collected
at 30 min intervals for the first 2 h, 1 h intervals for next
4 h and finally at 9, 12, 24 and 48 h post-ingestion (the
latter two were collected at 08.00 h on study days 2
and 3). Subjects also collected their urine as four 3 h
collections (i.e. 08.00-11.00 h, 11.00-14.00 h, 14.00-17.00 h
and 17.00-20.00 h) plus three 12 h collections (i.e. 20.00 h
study day 1 to 08.00 h study day 2, 08.00 h study day 2 to
20.00 h study day 2, 20.00 h study day 2 to 08.00 h study
day 3) in separate pre-weighed, pre-cleaned plastic con-
tainers. Additionally, subjects also collected all their faeces
over the 48 h post-dose period as two 24 h collections
(08.00 h study day 1 to 08.00 h study day 2, 08.00 h study
day 2 to 08.00 h study day 3) in containers provided. A
summary of the study design is shown in Figure 1.
Standardized meals
All 12 participants received the same meals, and the same
amount of each meal, for breakfast, lunch and dinner
during the study/sample collection periods: namely,
study day 0 (baseline collection), study day 1 and study day
2. Males and females received the same amount of each
meal and therefore their silicon intakes were identical. The
contribution of Si from the three meals was estimated fromFigure 1 Study design. Summary of the timing of ingestion of the tes
shown by thick black arrow) and standardised meals (down arrows), a
samples (collection periods indicated). Pre-dose (baseline; light grey) andreference food Si values [5,18] or from direct analysis
(i.e. drinking water) and was, on average, 24 mg Si/day
over the study period (Table 2). Meals were eaten as
follows: breakfast at 08.00 h for study day 0 and study
day 2, and at 12.30 h for study day 1 as subjects remained
fasted until then; lunch at 12.30 h for study day 0 and
study day 2, and at 16.30 h on study day 1; dinner at
18.30 h for study day 0 and study day 2, and at 20.30 h on
study day 1. The total intake of Si from the meals on study
day 1 was 23.86 mg. All subjects ate at the same times.
Sample preparations
Serum samples Blood samples were collected in 15 mL
polypropylene tubes and left to stand for at least 1 h at
room temperature to clot. The clotted blood samples
were then centrifuged (Hettich Zentrifugen, Tuttlingen,
Germany) at 3,000 rpm for 10 min at room temperature.
The separated serum fractions were collected into new
15 mL polypropylene transport tubes and stored at −20°C
until elemental analysis. Prior to analysis, the serum
samples were thawed at room temperature (23°C) and
then diluted 1 + 4 with 0.25% (v/v) high purity HNO3.
Urine samples Urine collections were weighed and vol-
umes calculated assuming a density of 1. After thorough
mixing, a 10 mL homogenous sample was collected into a
30 mL polypropylene bottle and diluted with equi-volume
0.7% (v/v) high purity HNO3 (i.e. 1 + 1 dilution) to reduce
any precipitation during storage [19]. The diluted samples
were stored at 4°C until elemental analysis. Prior to
analysis, the diluted samples were incubated overnight
in their closed containers at 40°C in an oven to dissolve
any precipitates that may have formed during storage
[19]. Samples were cooled to room temperature prior
to total elemental analysis for Si.
Faecal samples Faecal collections were weighed and after
thorough manual mixing with a disposable wooden spatula,t solutions (Si-supplement or ultra-high purity water; Si/H2O
nd the collection of serum (thin up arrows), urine and faecal
post-dose (dark grey) collections are indicated.
Table 2 Estimated silicon content1 of the meals (mg Si/meal) provided to all participants during the study period
Meals Components Day 03 (mg Si) Day 1 (mg Si) Day 2 (mg Si)
Breakfast Egg fried rice with pork/chicken, orange juice, drinking water2 6.78 7.70 7.34
Lunch Rice with chicken, drinking water2, yogurt, sponge cake 7.59 7.33 9.01
Dinner Rice with stir-fried pork/chicken with kale, melon, drinking water2 9.93 7.43 7.97
Total Si intake per day 24.29 23.86 23.91
1Calculated from reference food Si values (5, 18).
2Produced from tap water by reverse osmosis (Si concentration = 0.67 mg Si/L as analysed here by ICP-OES).
3Day 0 = pre-dose, baseline collection period, conducted 24 h prior to ingestion of the test solutions on day 1.
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into a 50 mL polypropylene bottle and stored at −20°C.
Prior to analysis, approximately 0.25-0.5 g of the faecal
samples was digested with an equi-volume (5 mL) of
concentrated (65% (w/v)) HNO3 and hydrogen peroxide
(30-40%) at room temperature for 24 h. These were incu-
bated at 40°C until total digestion was obtained. Sample
(acid) blanks were similarly prepared. An aliquot (1 mL)
of the digested samples and sample blanks were diluted
with 5 mL UHP water prior to total element analysis
for Si.
Total elemental analysis
Total elemental analysis for Si was carried out (at
251.611 nm) by ICP-OES; Perkin Elmer Optima model
2100 DV, equipped with a Cross flow nebuliser and Cyc-
lonic spray chamber. Nebulizer flow rate was 0.8 L/min.
Peak area was 7.7 points and integration times were 20 sec-
onds/analysis/element. Sample flow rate was 2 mL/min.
Matrix matched standards, sample blanks, diluents and
quality control samples were run alongside the samples.
Serum, urine and faecal samples The diluted serum,
urine, and faecal samples from the same subject were
analyzed together in the same batch. Sample-based stan-
dards were prepared in the pooled diluted sera, baseline
urine, or baseline faecal samples using the 1,000 mg/L Si
ICP standard solution.
Test solutions The Si supplement solution, UHP water
and drinking water (part of standardized meals) were also
analyzed for Si by ICP-OES using appropriate standards.
Sample diluents As the serum and urine samples were
diluted with 0.25-0.7% HNO3, Si content of the acid
diluents was also measured by ICP-OES. Although minor,
this contaminant Si was subtracted from each of the
sample data.
Statistical analysis
Sample size (power) calculation was based on the available
data on urinary Si excretion [20]. No previous data exist
for faecal Si excretion. A relative standard deviation (σ) of
9.4% [20] was estimated for the variance in urinary Si anda potential difference of 20% for the excretion of urin-
ary Si between the Si supplement and water test solu-
tions was assumed, with 90% power at a 5% significance
level. Sample size formula for the difference of two inde-
pendent means was used for the calculation and six com-
pleted subjects were the minimum required for each test
solution.
Area under the curve (AUC) of serum Si was calculated
using the linear trapezoidal rule [21]. Due to a small num-
ber of subjects in each group, differences in serum AUC,
and in urinary and faecal excretions of Si, between the two
groups (Si vs. control), were analysed non-parametrically
using the Mann–Whitney Rank test. Statistical analyses
were two sided and a P value ≤ 0.05 was considered signifi-
cant. SPSS for Windows version 13.0 (SPSS Inc., Chicago,
Illinois, USA) was used for all statistical analyses.
Results
Gender specific analysis showed no significant difference
in silicon absorption, excretion (urinary and fecal) and
balance between male and female subjects and so the
combined (pooled) dataset is shown for clarity and because
of the small number of subjects.
Serum Si absorption
Mean baseline serum Si concentrations were similar in the
control and the Si-supplemented groups (114 ± 17 μg/L
(range 85 – 130 μg/L) vs. 112 ± 26 μg/L (range 83 –
148 μg/L)) and remained close to baseline in the control
group following ingestion of UHP water (Figure 2A).
In contrast, and as expected, serum Si concentrations
increased markedly above baseline following ingestion
of the orthosilicic acid solution (28.9 mg Si in UHP water)
in the Si-supplemented group, with peak Si concentration
(206 ± 48 μg/L; range: 133 – 250 μg/L) observed 1 to 2
hours post-ingestion (Figure 2A). Thereafter, serum Si
concentrations began to drop rapidly back towards baseline
concentrations. However, the ingestion of meals at 4.5 h
and 8.5 h post-dose maintained serum Si concentrations
above baseline in the Si-supplemented group and increased
Si concentration above baseline in the control group, until
12 h post-dose. Area under the curve (AUC) of serum
Si over the 24 h period was not significantly different
between the two test solutions. However, AUC for the
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Figure 2 Serum Si absorption and urinary Si excretion following ingestion of the test solutions. (A) Serum silicon absorption. Serum Si
following ingestion of UHP water alone (◯―◯; Control group) or following ingestion of UHP water containing 28.9 mg Si as orthosilicic acid
(●―● Si-supplemented group). Data are means ± SE of 6 subjects per group. The large arrow below the x-axis indicates the time of
ingestion of the test solutions (i.e. t = 0). *P = 0.009 (Mann–Whitney Rank test). (B and C) Urinary silicon excretion. Urinary excretion of
Si following ingestion of UHP water alone (stripped bars; Control group) and UHP water containing 28.9 mg Si as orthosilicic acid
(grey bars; Si-supplemented group). (B) Silicon levels in the 12-h urine collections over the 48 h study period. (C) The insert shows more
detailed analysis of Si output over the first 12 h following ingestion of the test solutions. Data are means ± SD of 6 subjects per group.
*P = 0.009, **P = 0.002 (Mann–Whitney Rank test).
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nificantly higher following ingestion of orthosilicic acid
solution, compared to UHP water alone (648 ± 137 mg h/L
(range 459 – 819 mg h/L) vs. 453 ± 104 mg h/L (range
319 – 630 mg h/L); P = 0.04).
Urinary Si excretion
Mean total baseline 24 h urinary Si excretion was 12.48 ±
2.26 (range 9.72 – 15.31) and 12.93 ± 2.85 (range 9.11 –
16.34) mg, respectively, in the control and Si-supplemented
groups and did not change markedly in the control group
following ingestion of UHP water (13.34 ± 2.48 mg; range
11.36 – 18.21 mg). In contrast, in the Si-supplemented
group, ingestion of the orthosilicic acid solution (28.9 mgSi in UHP water) led to a marked increase in urinary ex-
cretion of Si in the 0–12 h post-dose collection (P = 0.002;
Figure 2B). A more detailed analysis of the 0–12 h collec-
tion in the Si-supplemented group showed that the peak
increase in Si output was at 0–3 h post-dose (Figure 2C).
Again, the ingestion of meals at 4.5 h and 8.5 h post-dose
maintained urinary Si output above baseline in the 6–9 h
and 9–12 h post-dose collections, as clearly mirrored in
the control group (Figure 1C). Urinary Si output in the
remaining collections (12–24 h, 24–36 h and 36–48 h),
were comparable to baseline levels and similar between
the two groups.
The increase in urinary Si output in the Si-supplemented
group over the 24 h post-dose period following ingestion
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line urinary Si excretion) was 16.5 ± 2.7 mg (range 14.4 –
20.5 mg) and this accounted for 57.0 ± 9.5% (range 49.8 –
71.0%) of the supplemental Si dose (28.9 mg) ingested.
Faecal Si excretion
Mean total baseline 24 h faecal excretion of Si was 9.5 ± 1.4
(range 8.0 – 11.5) and 9.4 ± 2.0 (range 6.7 – 11.5) mg,
respectively, in the control and Si-supplemented groups
(Figure 3) and did not change markedly in the control
group following ingestion of UHP water. However, the
ingestion of the orthosilicic acid solution led to a significant
increase in faecal Si content in the 24 h post-dose collection
compared to baseline (P = 0.002; Figure 3). This increase
in faecal Si excretion in the Si-supplemented group, by +
11.4 ± 2.7 mg (range + 7.6 – 14.9 mg) over 0–24 h period,
accounted for 39.3 ± 9.4% (range: 26.4 – 51.6%) of the
ingested supplemental Si dose (28.9 mg).
Silicon balance
In the Control group urinary and faecal Si excretion over
the 24 h post-dose period accounted for 99.6 ± 8.1% (range
90.6 – 112.9%) of the total Si intake over that period, whilst
in the Si-supplemented group average recovery from urine
and faeces was slightly less at 94.8 ± 9.4% (range 83.3 –
105.6%; Table 3). Of the supplemental Si dose ingested
(28.89 mg), 27.83 ± 1.67 (range 25.6 – 29.5) mg (or 96.3 ±
5.8%; range 88.5 – 102.2%) was recovered from urinary
and faecal excretion over the 24 h post-dose period in the
Si-supplemented group.
Discussion
The present study investigated the balance in excretion
of silicon versus its intake, using a single dose of typicalBaseline 24 h 0-24 h post-dose
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Figure 3 Faecal silicon excretion. Mean (± SD) faecal excretion of
Si following ingestion of UHP water (stripped bars) and UHP water
containing 28.9 mg Si (grey bars) in six subjects. *P = 0.002 (Mann–
Whitney Rank test).dietary silicon (28.9 mg) in healthy human volunteers on
a standardized diet. Our results show that, within error,
all (96 ± 6%) of the ingested dose was excreted in urine
and faeces over the 24 h post-dose period. Whether it is,
fully, the same Si being excreted that is being absorbed
will need to be addressed with a different study design.
However, to get within 5% of intake with variance of ~ 6%
is better than may have been expected, especially with the
complexities of faecal and urine collection and analysis
[17,22]. Typical recovery from such studies, even with
radiolabelled compounds, can be 80% or less, much less
than from animal studies [23,24]. The high renal clearance
of Si and the lack of interaction with serum proteins
probably aids recovery [25,26].
As mentioned previously, 100% recovery is expected if
(a) Si metabolism is regulated but the subjects are in Si
balance (i.e. are Si replete) or (b) if Si has no active bio-
logical function and thus Si metabolism is not regulated
at all. This study cannot prove which is true but we believe
that the former is more likely based on previous murine
data where urinary Si output was found to be conserved
in Si-deprived animals to maintain tissue Si levels [15]. To
now show this in humans we will need to repeat the study
with subjects who are in negative Si balance (i.e. Si deplete
at the start of the supplementation period by prior dietary
Si deprivation for a week or so). Supplementation with the
Si dose should then result in less Si being excreted, as
more is retained to replenish the depleted body Si pool,
compared to a Si-replete group.
Secondly, from this current work, we cannot be certain
that the Si excreted in urine and faeces all originated from
the ingested Si dose and that there was not some exchange
with the body Si pool- as for example occurs with dietary
phosphate [27]. This can only be answered with an isotope
label study, where isotopic Si is used for the dose solution
to discriminate it from Si of the body pool and from dietary
sources (i.e. the meals ingested). However this is also not
straight forward. 31Si and 32Si are both radioactive and
would result in exposure to radiation (beta decay) with
short (t½ = 157 min) or long (t½ = 153 years) half-lives,
respectively. Using a stable isotope such as 29Si would
avoid radioactive exposure but it has a high natural
abundance (ca. 5% of all endogenous Si(OH)4). Hence,
a relatively accurate balance, as now proven is possible
in this study, will be key to the success of the follow on
stable isotope work. Moreover, with recent develop-
ments in inductively coupled plasma – mass spectrometry
methods, to measure 28Si and 29Si in biological samples
[28], we are confident that it will now be possible to
discriminate the source of excreted Si (i.e. all ‘washed
through’ following ingestion or some from the body
pool following exchange with absorbed silicon). Both
this question and that of Si retention following oral Si
challenge to Si-depleted volunteers are big questions in
Table 3 Silicon intake, excretion, and balance over 24 h period (study day 1)
Control group (n = 6) Si-supplemented group (n = 6)
Mean ± SD Range Mean ± SD Range
Silicon intake
Si supplement (mg) - 28.89
Dietary Si intake (mg) 23.86 23.86
Total Si intake (mg/24 h) 23.86 52.75
Silicon excretion
Urinary Si (mg/24 h) 13.34 ± 2.48 (11.36–18.21) 29.41 ± 3.55 (25.44–35.78)
Faecal Si (mg/24 h) 10.74 ± 1.41 (8.74–12.02) 19.96 ± 4.58 (14.31–25.53)
Total excretion (mg/24 h) 23.77 ± 1.94 (21.62–26.95) 50.02 ± 4.98 (43.93–55.68)
Silicon balance (mg) 0.09 ± 1.94 (−3.09–2.24) 2.73 ± 4.98 (−2.93–8.82)
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may now be answered with carefully designed isotopic
balance studies in Si replete and deplete individuals. In
the work presented herein subjects were carefully matched
to reduce variability between the two groups, however a
cross-over design is undoubtedly more robust to really
minimise inter-individual variation in silicon handling
[29,30]. Thus, although more burdensome to the subjects,
for the future work a cross-over study design will be
seriously considered.
Finally, measurement of faecal Si excretion for the first
time in a human study, as we report here, allowed the
absolute absorption of Si from the orthosilicic acid dose
solution to be estimated which, at 61 ± 9% of the ingested
dose, is similar to the estimate from total urinary Si output
over the 24 h collection period (57 ± 10%). These estimates
are comparable with previous data (absorption being stated
as ~ 50–60% of the ingested dose) from shorter urine
collections, 0–6 or 0–8 h post-dose [20,25,29-34]. Hence,
we can conclude that (a) urinary silicon does measure
silicon absorption following oral Si challenge and (b) in
general 0–6 or 0–8 h urinary collections are adequate
to estimate absorption/bioavailability of Si from readily
absorbed dietary sources, supplements and test solutions
(Si materials requiring prolonged digestion prior to absorp-
tion may differ in this respect as previously noted [30].
Conclusions
In conclusion the present study reports that urinary and
faecal Si excretion can be measured with high precision
(with inter-subject variance ~ 6%) and that in normal
healthy subjects who are presumed to be in Si balance,
ingestion of a soluble dose of Si results in an equivalent
quantity being excreted within 24 h. We confirm that
urinary silicon may be used as an accurate measure of
silicon absorption, assuming robust study design. This
work also provides clear evidence that a proper isotope-
based balance study can now be undertaken in silicon
replete and depleted volunteers to inform on homeostasisof silicon and thus provide strong evidence (or not) for
beneficial utilisation of the element by humans.
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